Microextraction by packed sorbent (MEPS) was used to handle whole mice blood samples. MEPS was used as an online rapid sample-preparation method, followed by liquid chromatography with tandem mass spectrometry (LC-MS/MS). Cyclophosphamide in mice blood was used as a model compound. The new method reduced the handling time and the cost and could handle small volumes of whole blood samples (20 μL). The lower limit of quantification (LLOQ) was 0.1μg/mL. The accuracy of the quality-control (QC) samples ranged from 107 to 110 %. The within-day variation was within the range 2.0-7.0% (C.V.%) while the between-day variation was between 4.0 and 6.0% (C.V.%). The calibration curve in whole blood was constructed within the concentration range 0.1-100 μg/mL. The coefficients of determination (R 2 ) were > 0.99 (n = 3). The present method is rapid, reliable and accurate and may be used for therapeutic drug monitoring of cyclophosphamide in whole blood. The method was applied for preclinical study of cyclophosphamide in mice.
INTRODUCTION
The sample preparation is the first and important stage in chromatographic bioanalysis. In cases when the analytes are present in a complex matrix, e.g. blood or urine, the sample preparation is of crucial importance for the analysis. Today the extraction of drugs and metabolites from biological samples has been changed in many ways. There is an everincreasing interest in the direct analysis of whole blood samples. The demands on a sample preparation procedure are: it must be highly repeatable, with a high recovery of the target analytes. In addition, direct analysis of blood samples should reduce the sample handling time and involve a minimum number of working steps. Micro extraction by packed sorbent (MEPS) is a miniaturized solid phase extraction (SPE) cartridge integrated into a gas tight syringe that can be connected online to GC or LC without any modification. The MEPS consists of two parts, the MEPS Syringe (100, 250 μL) and the MEPS Barrel Insert and Needle Assembly (BIN) that contains about 2 mg of sorbent. The dead volume is about 7 μL. In MEPS the volume of solvent used to elute the analytes from the extraction process is of a suitable order of *Address correspondence to this author at the Department of Chemistry & Biomedical Sciences, Faculty of Technology and Science, Karlstad University, SE-651 88 Karlstad, Sweden; E-mail: Mohamed.Abdel-Rehim@astrazeneca.com magnitude to be injected directly into a LC or GC system. Effectively, MEPS is an LC column in a syringe. The bed dimensions are scaled from the conventional SPE bed and so MEPS can be adapted into most existing SPE methods simply by scaling the reagents and sample volumes from the conventional device to the MEPS. The technique has been employed to extract a wide range of analytes in many areas [1] [2] [3] [4] [5] [6] .
The aim of the present study was to investigate MEPS as sample preparation method to handle small whole blood samples ( 20 μL). Cyclophosphamide in whole mice blood, from a preclinical study, was used as a model substance. Cyclophosphamide is one of the most used anti-cancer drugs [7, 8] . It is used in the treatment of malignant diseases such as leukemia, lymphoma and solid tumors.
MATERIAL AND METHODS

Chemicals and Materials
Cyclophosphamide was purchased from Sigma Chemical Company (St. Louis, MO, USA). Internal standard was 2 H 3 -lidocaine and obtained from Department of Medicinal Chemistry, AstraZeneca, Södertälje, Sweden. Acetonitrile, methanol, formic acid and ammonium hydroxide were obtained from Merck (Darmstadt, Germany). All chemicals were of analytical grade. The Milli-Q water used was ob-tained from Reagent Grade Milli-Q Plus water purification system (Millipore Corporation, Bedford, USA).
Apparatus
MEPS-LC-MS/MS:
The MEPS syringe (Fig. 1) , (250 μL syringe, C2 sorbent) was obtained from SGE (Melbourne, Australia). All experiments were conducted using a triple quadrupole mass spectrometric instrument, Micromass QuatroUltima (Waters Corporation, Manchester, UK) equipped with a Z-electrospray interface operated in positive ion mode. The scan mode was multiple reaction monitoring (MRM) using precursor ion at (M+1) (m/z: 261 and 237.9) and after collisional dissociation the product ions m/z: 140 and 86 were used for quantification of cyclophosphamide and the internal standard, respectively. The optimum mass spectrometric parameter settings were: capillary voltage at 3 kV, cone voltage at 27 V, extractor at 5 V, RF lens at 0.2 V, source block and desolvation temperatures at 150 °C and 300 °C, respectively. Nitrogen was used both as drying (400 L h -1 ), and nebulizing gases (20 L h -1 ); the vacuum was 2x10 -5 mbar in the mass analyzer and 2x10 -3 mbar in the collision cell. Argon was used as collision gas and collision energy was 22 eV. The gases were from ScanGas (Stockholm, Sweden). The data were collected and processed using MassLynx version 4.0, and all calculations were based on peak area ratios.
Two mice groups were administered cylophosphamide intraperitoneally at a dose of 100 mg/kg and blood samples were collected 0.25, 0.5, 1, 2, 3, 4, 5 and 6 hours. The blood samples were collected serially from the tail vein and about 20 L of blood was collected using syringe containing 80 L 0.5M EDTA. All samples were stored in a freezer set at -20°C until its analysis.
Sample Preparation
The calibration curve in whole blood was obtained in the concentration range 0.1-100 μg/mL (0.1, 0.5, 1.0, 10, 25, 50 and 100 mg/mL). Quality control (QC) samples concentrations were 0.4, 40 and 80 μg/mL. Aliquots of 20 μL of blood samples, standards and QC samples, were diluted with water (1:25) and 20 μL of IS (40 μg/mL) was added before MEPS extraction. The MEPS sorbent was manually conditioned with 50 L methanol followed by 50 L of water. After that, the syringe was connected to the autosampler and the spiked blood was withdrawn into the syringe by the autosampler. The sorbent was then washed by CTC-autosampler once with 100 L of water/methanol (95:5, v/v) to remove proteins and other interferences. The analytes were then desorbed by 40 μL methanol/water 90:10 (v/v) directly into the LC injector. Cleaning of the sorbent was carried out using 4x250 L elution solution followed by 4x250 L of the washing solution after every extraction. This step decreased memory effects, but also functioned as conditioning step before the next extraction. The same packing bed was used for about 40-100 extractions before it was discarded. 
Validation
Each calibration curve consisted of seven calibration points in mice blood covering from 0.1 μg/mL to 100 μg/mL. Blank samples were run simultaneously. The peak area ratios for cyclophosphamide and internal standard were measured and a calibration curve without zero concentration was constructed. The calibration curves were described by the equation:
where y is peak area ratio, x the concentration, a curvature, b the slope and c the intercept. The calibration curves were quadric and the weight was 1/x. The accuracy and precision were calculated for the QC samples at three different assays.
Accuracy was defined as the degree of deviation of the determined value and the nominal value: [(measured valuenominal value) / nominal value] * 100. Precision (C.V. %) was defined as the percentage of standard deviation of the observed values divided by their mean values: [(standard deviation) / mean value]* 100.
RESULTS AND DISCUSSION
Calibrations
Linear calibration curves of blood samples spiked with cyclophosphamide standards were obtained in the range 0.1-100 μg/mL. The coefficients of determination (R 2 ) were > 0.99 (n = 3). Table 1 shows the back-calculated values of standard calibration samples in whole blood. 
Selectivity and Matrix Effect
The method selectivity was defined as non-interference with the endogenous substances in the regions of interest. LC-MS/MS analysis of the blank blood samples showed no presence of an endogenous interference peak with the quantification of cyclophosphamide. Representative chromatograms of blank mice blood and spiked blood are presented in (Fig. 3) .
In addition, the matrix effect on ionization was investigated by post-column continuous infusion of cyclophosphamide solution into the MS instrument and a pre-treated blank blood sample was injected into LC-MS. No ion suppression was observed at the retention time of cyclophosphamide.
Accuracy and Precision
The QC samples were prepared in mice blood. The accuracy is determined as the percentage difference from the nominal concentration value of QC samples (n = 12) at three different concentration levels. The between-day mean accuracy ranged from 107 to 109%. The within-day variation of the precision (C.V.%) was in the range 2.0-7.0%. The between-day variation of the precision (C.V.%) was in the range 4.0-6.0%. The accuracy and precision results are summarized in Table 2 . Table 2 
Extraction Recovery, Lower Limit of Quantification and Carry-Over
The extraction recovery was determined by comparing the peak area of the extracted analyte from mice blood at two different concentrations (low-and high-quality control sam- Fig. (3) . Total ion chromatogram of the MRM analysis from: (A) mice blood spiked with cyclophosphamide 0.1 μg/mL (LLOQ) and I.S.; (B) blank blood sample.
ples) with the peak area obtained from standards prepared in mobile phase. The extraction recovery was over 90% when the sample was pumped four times (4 x 100 μL).
The lower limit of quantification (LLOQ) in mice blood was measured at 0.1 g/mL (Fig. 3A) . Fig. (4) . Total ion chromatogram of the MRM analysis from (A) mice blood spiked with cyclophosphamide 5.0 μg/mL and three blank samples were injected after.
The precision (C.V.%) for LLOQ was 5% (n = 12). The small amount of solid phase in the MEPS can be easily and effectively washed between samples to reduce the possibility of carry-over. After each injection, the syringe was washed five times with water and five times with methanol. The carry-over was about 0.4% after the first blank and after the third blank it was negligible (Fig. 4). 
Method Comparison
Many previous methods used for the determination of the cyclophosphamide in plasma samples were performed using different sample preparation methods. In previous studies we used MEPS for extraction of drugs and metabolites from plasma and urine samples. In this paper we present, for first time, MEPS as a sample preparation method for the extraction of cyclophosphamide from whole blood samples. On the other hand it is important to mention that, further development of this assay is warranted to determine both cyclophosphamide and its active metabolites that may contribute to the clinical effects of the drug. Other research groups have adopted LC-MS techniques and LLE or SPE for the simultaneous determination of cyclophosphamide and its metabolites in plasma and tissue and have applied these assays in clinical and experimental trials. However, these methods [9] [10] [11] [12] require long time work-up procedure. In the present study, we report a sample preparation method for whole blood, MEPS, that requires a few microliters of sample and extraction time for less than one minute.
The present method may play an important role to replace the old sample preparation methods and can be of a great advantage for therapeutic drug monitoring.
Application of the Method
In order to demonstrate the applicability of the proposed method, it was used to determine cyclophosphamide in mice blood samples from a preclinical study. A typical chromatogram of this type of samples appears in Fig. (5) , where the concentration of cyclophosphamide found was 1.9μg/mL, resulting from a dose of 100 mg/kg administered. 
CONCLUSIONS
This study has demonstrated that the combination of MEPS with LC-MS/MS can be a very useful tool for determination of drugs directly in a whole blood samples. The method is rapid and accurate for the determination of cyclophosphamide in whole blood. We demonstrated that carryover may be almost eliminated by washing the sorbent with elution and washing solutions. This approach to sample preparation is very promising for many reasons: 1) it is easy to use, 2) it is a fully automated online procedure, 3) it is rapid, and 4) the cost of analysis is minimal compared to conventional solid-phase extraction. Not only is the automation process with MEPS advantageous, but also the much smaller volumes of the samples and solvents provide other significant advantages such as the speed and the simplicity of the sample preparation process.
